$10.71
-0.04-0.37%
Last update: Oct 30, 7:56 PM
Xeris Biopharma Holdings Inc (XERS) Stock Price, Quote, News & History
XERSNASDAQ
U.S. stocks fell as Nasdaq dropped 100+ points, while TriSalus surged 5.8% on FDA clearance; Securitize, Lakefront and others also gained.
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Other companies in Xeris Biopharma Holdings’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Xeris Biopharma Holdings has a consensus price target of $11.38.
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $10.7383 last updated October 30, 2026 at 7:56 PM EDT.
There are no upcoming dividends for Xeris Biopharma Holdings.
Xeris Biopharma Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for Xeris Biopharma Holdings.
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of...
